Locsense develops and supplies barrier integrity monitoring equipment for early stage research in the pharmaceutical, food and cosmetics industry. Our flagship device, the Locsense Artemis, is a non-invasive sensor that monitors cell growth and cell health in conventional transwell plates with inserts. Locsense is at the forefront of lab technology with devices that non-invasively monitor and test cells outside the body. In our bodies, cells often form protective barriers. Think of these barriers as tiny walls that separate different areas. For example, the lining of your gut has cells that create a barrier between your food and the rest of your body, or the skin which forms a protective barrier for influences from outside. Impedance measurements offer a way to measure how strong these barriers are and whether they are intact. The Artemis offers insight into how healthy cell barriers are. This is crucial for drug testing, studying diseases, and making sure our body’s defenses work properly. Our products are designed to combine with conventional workflow. At the same time they can be coupled to innovative in-vitro cell culture platforms, such as microfluidic chips, organs-on-chip or smartplates.
Looking for a particular Locsense employee's phone or email?
The Locsense annual revenue was $5 million in 2026.
Susan Roelofs is the CEO and founder of Locsense.
4 people are employed at Locsense.
Locsense is based in Enschede, Overijssel.
The NAICS codes for Locsense are [33, 31, 32, 325, 312, 3122].
The SIC codes for Locsense are [21, 283, 20, 28].